ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
New Idea: Four Compound TAMO intranasal ED & Libido Formulation
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 254268" data-attributes="member: 3"><p>I am trying to get a formulation combining these four compounds in an intranasal form.</p><p></p><p>Tadalafil:</p><p>Similar to sildenafil, tadalafil, another PDE5 inhibitor, has also been investigated for intranasal delivery. Studies have shown that <a href="https://pubmed.ncbi.nlm.nih.gov/31215307/" target="_blank">intranasal tadalafil</a> can rapidly reach systemic circulation, leading to a quicker onset of action compared to oral tadalafil. This route of administration may offer advantages for patients who desire more spontaneous sexual activity.</p><p></p><p>Apomorphine:</p><p>Apomorphine is a non-selective dopamine agonist that has shown potential as an intranasal therapy for ED. It acts by stimulating dopamine receptors in the brain, enhancing the release of nitric oxide, and promoting penile smooth muscle relaxation. <a href="https://pubmed.ncbi.nlm.nih.gov/15154111/" target="_blank">Intranasal apomorphin</a>e has demonstrated promising results in improving erectile function, particularly in patients with neurogenic ED or those who do not respond well to PDE5 inhibitors.</p><p></p><p>Melanocortin receptor agonists:</p><p>Melanocortin receptor agonists, such as bremelanotide, have been investigated for their potential in treating ED. <a href="https://pubmed.ncbi.nlm.nih.gov/14963471/" target="_blank">Intranasal bremelanotide</a> acts on the central nervous system to promote sexual arousal and improve erectile function. Clinical trials have shown positive outcomes in terms of increased sexual desire and improved erectile function in patients with ED.</p><p></p><p>Oxytocin:</p><p>Oxytocin, a hormone involved in social bonding and sexual behavior, has been studied for its potential role in the treatment of ED. <a href="https://pubmed.ncbi.nlm.nih.gov/24503174/" target="_blank">Intranasal oxytocin</a> administration has shown promise in improving sexual function, desire, and satisfaction in both men and women. It may have a positive impact on psychogenic and functional ED.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 254268, member: 3"] I am trying to get a formulation combining these four compounds in an intranasal form. Tadalafil: Similar to sildenafil, tadalafil, another PDE5 inhibitor, has also been investigated for intranasal delivery. Studies have shown that [URL='https://pubmed.ncbi.nlm.nih.gov/31215307/']intranasal tadalafil[/URL] can rapidly reach systemic circulation, leading to a quicker onset of action compared to oral tadalafil. This route of administration may offer advantages for patients who desire more spontaneous sexual activity. Apomorphine: Apomorphine is a non-selective dopamine agonist that has shown potential as an intranasal therapy for ED. It acts by stimulating dopamine receptors in the brain, enhancing the release of nitric oxide, and promoting penile smooth muscle relaxation. [URL='https://pubmed.ncbi.nlm.nih.gov/15154111/']Intranasal apomorphin[/URL]e has demonstrated promising results in improving erectile function, particularly in patients with neurogenic ED or those who do not respond well to PDE5 inhibitors. Melanocortin receptor agonists: Melanocortin receptor agonists, such as bremelanotide, have been investigated for their potential in treating ED. [URL='https://pubmed.ncbi.nlm.nih.gov/14963471/']Intranasal bremelanotide[/URL] acts on the central nervous system to promote sexual arousal and improve erectile function. Clinical trials have shown positive outcomes in terms of increased sexual desire and improved erectile function in patients with ED. Oxytocin: Oxytocin, a hormone involved in social bonding and sexual behavior, has been studied for its potential role in the treatment of ED. [URL='https://pubmed.ncbi.nlm.nih.gov/24503174/']Intranasal oxytocin[/URL] administration has shown promise in improving sexual function, desire, and satisfaction in both men and women. It may have a positive impact on psychogenic and functional ED. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
New Idea: Four Compound TAMO intranasal ED & Libido Formulation
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top